DRD2 rs1800496: Understanding This Dopamine Receptor Variant
The rs1800496 variant is a genetic change located within the DRD2 gene, which encodes the dopamine D2 receptor. Research has explored its potential associations with reward processing, cognitive flexibility, and various behavioral traits, though the evidence remains limited and complex.
What each genotype means
Typical dopamine receptor profile
This genotype represents the most common form of this variant. Research into this specific site suggests it may be involved in aspects of reward processing and cognitive flexibility, though evidence remains limited and associations are not diagnostic of any specific trait or condition.
This is the most prevalent genotype across most global populations.
Varied dopamine receptor profile
Carrying one copy of the T allele means your genetic profile for this variant differs from the most common form. Studies have explored potential links between this variant and behavioral traits like sensory preference, but current scientific evidence is limited and findings are often inconsistent across different studies.
This heterozygous genotype is found at moderate frequencies in many populations, varying by ancestry.
Alternative dopamine receptor profile
This genotype represents the less common homozygous state for this variant. While some research has investigated its role in cognitive and behavioral processing, the evidence is considered limited and does not indicate a specific health outcome or clinical diagnosis.
This genotype is the least common of the three, with frequencies that vary significantly depending on ancestral background.
What is rs1800496?
The variant rs1800496 is a single nucleotide polymorphism (SNP) located within the DRD2 gene on chromosome 11. In genetic databases, it is often identified by the specific change from a cytosine (C) to a thymine (T) nucleotide. Because this variant is located in an intronic region—a non-coding part of the gene—it does not directly alter the amino acid sequence of the resulting protein. Instead, researchers investigate whether such variants might influence how the gene is expressed, spliced, or regulated within the brain. As an intronic variant, its functional impact is not as straightforward as a mutation that changes a protein's structure, which is why scientists often describe the evidence for its specific phenotypic effects as limited or mixed.
The Role of the DRD2 Gene
The DRD2 gene provides instructions for making the dopamine D2 receptor, a protein found primarily in the brain. Dopamine is a critical neurotransmitter that acts as a chemical messenger, helping to regulate movement, motivation, reward, and cognitive function. The D2 receptor is a G protein-coupled receptor that helps modulate these signals. Because dopamine pathways are central to how we experience pleasure and make decisions, variations in the DRD2 gene have been studied extensively in the context of neuropsychiatric conditions and behavioral traits. While the gene is well-understood in its biological function, linking specific intronic SNPs like rs1800496 to complex human behaviors remains a significant challenge in genomics, as these traits are influenced by hundreds of other genetic and environmental factors.
Research and Evidence Strength
Scientific literature has examined rs1800496 in relation to reward processing, cognitive flexibility, and sensory preferences. However, it is important to note that the evidence strength for these associations is generally considered limited. Many studies in this field are case-control or family-based, and results can be inconsistent across different cohorts or ethnic groups. While some reports suggest correlations with behavioral traits, other studies have failed to replicate these findings, highlighting the complexity of genetic association studies. Because human behavior is polygenic—meaning it is influenced by many genes working together—a single SNP like rs1800496 rarely has a large, predictable effect on an individual's personality or cognitive profile. Consequently, findings regarding this variant should be viewed as statistical observations rather than definitive predictors of any specific trait.
Population Frequency
The frequency of the alleles for rs1800496 varies across different global populations. Data indicates that the G allele (often corresponding to the C allele in different strand orientations) has a frequency of approximately 0.15 to 0.20 in European populations and is slightly higher, ranging from 0.25 to 0.30, in East Asian populations. These variations are common in human genetics, reflecting the natural diversity found across different ancestral groups. Understanding these frequencies is essential for researchers to ensure that genetic studies are representative and to avoid drawing conclusions that may not apply broadly across all human populations.
Interpreting Your Genetic Information
If you have access to your genetic data, it is important to understand that a single variant like rs1800496 does not determine your behavior or health outcomes. Genetic associations are statistical, not deterministic. You cannot use this information to diagnose a condition or predict specific cognitive abilities. If you are concerned about how your genetics might relate to your health, or if you are taking medications that interact with dopamine pathways, you should discuss these topics with a qualified clinician or pharmacist. They can provide context based on your full medical history and current clinical guidelines. Avoid making health decisions based solely on individual SNP reports, as they lack the clinical context necessary for meaningful medical interpretation.
How common is this variant?
The G allele frequency is approximately 0.15-0.20 in European populations and 0.25-0.30 in East Asian populations.
Frequently asked questions
Can I use rs1800496 to predict my personality?
No. Personality is a complex trait influenced by a vast number of genetic and environmental factors. A single SNP like rs1800496 does not have the predictive power to determine personality traits.
Is rs1800496 associated with any diseases?
While some studies have explored links between DRD2 variants and neuropsychiatric conditions, the evidence for rs1800496 specifically is limited and often inconsistent. It is not considered a diagnostic marker for any disease.
Should I change my medication based on this SNP?
Absolutely not. Never alter your medication regimen based on genetic reports. Always consult with your doctor or pharmacist before making any changes to prescribed treatments.
Why do different studies show different results for this SNP?
Genetic association studies often vary due to differences in sample sizes, the ethnic backgrounds of participants, and the specific methodologies used. This is common in complex trait research.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800496?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This SNP in the DRD2 gene is frequently studied in the context of psychiatric genetics, particularly regarding dopamine receptor expression and schizophrenia risk.
This variant has been studied for its association with schizophrenia and dopaminergic signaling.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been investigated for associations with addiction susceptibility and antipsychotic response.
A synonymous coding variant in exon 7 of DRD2 that affects mRNA stability, translation kinetics, and dopamine-related working memory and reward phenotypes.
Known as the DRD2 TaqID polymorphism, this variant alters D2 dopamine receptor gene structure and is implicated in altered striatal dopamine functioning and substance use behavior.
A rare variant identified in the DRD2 gene, which is involved in the regulation of stress-induced behavioral responses.